300750 CONTEMPORARY AMPEREX TECHNOLOGY CO

GOOD Vision Unveils K-Shape™: A Revolutionary Corneal Topographer at The International Exhibition of Inventions of Geneva


EQS Newswire / 15/04/2024 / 10:00 CET/CEST

HONG KONG SAR - - 15 April 2024 - GOOD Vision Technologies Co., Limited, a Group in Ophthalmic Optics & Diagnostics, is introducing a game-changing corneal topography solution designed for use in patients as young as 4 years old at the International Exhibition of Inventions of Geneva. Supported by Hong Kong Science and Technology Parks Corporation's Incu-Bio Programme, a platform that supports the growth and development of biomedical tech start-ups in Hong Kong, GOOD Vision has developed a novel corneal topographer that aims to empower eye care practitioners with an efficient, accurate, and personalised option to enhance patient care.

This development aligns closely with the World Health Organization's 2030 targets for effective eye care coverage, addressing critical gaps in diagnosing and treating refractive errors. Astigmatism affects a substantial portion of the population, with a global prevalence of 40.4% in adults and 14.9% in children. Furthermore, there was a notable 1.5-fold increase in astigmatism cases in Hong Kong during the COVID lockdown, underscoring the critical need for advanced diagnostic tools such as GOOD Vision's corneal topographer - K-ShapeTM.

The innovative topographer outperforms existing devices with its flexibility, compact size, utilisation of normative data from Chinese populations, and affordability. By investigating subtle topographic changes on the cornea's front surface, the device allows for early diagnosis of vision conditions like astigmatism and corneal ectasia. This supports practitioners in assessing risks and facilitating timely interventions, which are critical for visual development in children.

Dr. Jason Lau, the Technical Director at GOOD Vision, said, "At GOOD Vision, we're setting new standards in eye care with K-ShapeTM. Based on our extensive study of over 900 Chinese children, our topographer is set to advance corneal reshaping, ensuring early intervention and personalised patient care. Our research revealed key insights into astigmatism and its broader impact, driving us to develop a tool that detects early corneal changes for prompt treatment, essential for healthy vision. As optometrists are in short supply globally, K-ShapeTM offers a way for practitioners to deliver precise, efficient care, particularly in early childhood screenings and clinical practice. Our diverse team, spanning university researchers to engineers, has worked tirelessly to bring K-ShapeTM from concept to market. We proudly showcase this game-changing technology at the International Exhibition of Inventions of Geneva."

K-ShapeTM incorporates advanced AI algorithms to swiftly and accurately identify corneal irregularities, ensuring precise image capture and facilitating on-the-spot data analysis. This AI integration increases efficiency in eye examinations and streamlines the workflow in clinical settings. By leveraging a proprietary normative database informed by extensive research on Hong Kong-based Chinese children, K-ShapeTM offers substantial insights into typical corneal astigmatism patterns within this demographic. This data underpins the development of a more accurate and tailored management approach for visual development from a young age. The debut of GOOD Vision's corneal topographer marks a transformative moment in the industry, significantly enhancing practitioners' ability to deliver personalised care.

GOOD Vision invites attendees to visit their booth at The International Exhibition of Inventions of Geneva to experience first-hand the future of corneal topography.

For additional details about GOOD Vision and their innovative offerings, please visit

Hashtag: #GOODvision #astigmatism #healthcare #eyecare #optometrist #eyecarepractitioner #ophthalmologist #conealtopographer #geneva

The issuer is solely responsible for the content of this announcement.

GOOD Vision Technologies Co., Limited

GOOD Vision is a Hong Kong-based startup dedicated to advancing the field of corneal reshaping technologies. With a focus on innovation, efficiency, and affordability, the company develops innovative solutions to empower eye practitioners and enhance the quality of eye care worldwide.

225647
News Source: GOOD Vision Technologies

15/04/2024 Dissemination of a Financial Press Release, transmitted by EQS News.
The issuer is solely responsible for the content of this announcement.

Media archive at

fncls.ssp?fn=show_t_gif&application_id=1880415&application_name=news&site_id=research_pool
EN
15/04/2024

Underlying

300750CONTEMPORARY AMPEREX TECHNOLOGY CO

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CONTEMPORARY AMPEREX TECHNOLOGY CO

 PRESS RELEASE

EQS-News: vbw Pressemitteilung zum Koalitionsvertrag: Gute Grundlage

Emittent / Herausgeber: ibw – Informationszentrale der Bayerischen Wirtschaft e. V. / Schlagwort(e): Sonstiges/Sonstiges vbw Pressemitteilung zum Koalitionsvertrag: Gute Grundlage 10.04.2025 / 09:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. vbw zum Koalitionsvertrag: Gute Grundlage Brossardt: „Koalitionsvertrag schafft Planungssicherheit und setzt Wachstumsimpulse“  Bertram Brossardt, Hauptgeschäftsführer der vbw – Vereinigung der Bayerischen Wirtschaft e. V.: (München, 09.04.2025). Wir freuen uns, dass jetzt der Weg frei ist f...

 PRESS RELEASE

Aquis Stock Exchange - suspension of trading

Aquis Stock Exchange Aquis Stock Exchange - suspension of trading 10-Apr-2025 / 07:00 GMT/BST The issuer is solely responsible for the content of this announcement. The following securities are suspended from trading on the Aquis Growth Market from 08.00, 10 April 2025, at the request of the company: Richmond Hill Resources Plc Ordinary Shares Symbol: SHNJ ISIN: GB00BNTBWF32 The Regulation Department Aquis Stock Exchange Floor 2, 63 Queen Victoria Street, EC4N 4UA Tel: 0203 597 6361 Email:  Website:  Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The i...

 PRESS RELEASE

EQS-News: CO2Coin one of the most successful crypto investments of the...

Issuer: Clima4Future Ltd. / Key word(s): Cryptocurrency / Blockchain/Market Launch CO2Coin one of the most successful crypto investments of the coming decades. 10.04.2025 / 04:55 CET/CEST The issuer is solely responsible for the content of this announcement.     CO2Coin is going through a phase of phenomenal growth. A year ago the price was just €1, today it is around 270 USDT - an increase in value that illustrates the enormous potential of this unique project. This development reflects the crypto community's growing interest in sustainable investments. Clima4Future Lt...

 PRESS RELEASE

EQS-News: CO2Coin eine der erfolgreichsten Krypto-Investitionen der ko...

Emittent / Herausgeber: Clima4Future Ltd. / Schlagwort(e): Kryptowährung / Blockchain/Markteinführung CO2Coin eine der erfolgreichsten Krypto-Investitionen der kommenden Jahrzehnte. 10.04.2025 / 04:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Der CO2Coin hat einen beeindruckenden Kursanstieg erlebt. Vor einem Jahr lag der Kurs noch bei 1 €, heute liegt er bei rund 270 USDT - eine Wertsteigerung, die das enorme Potenzial dieses einzigartigen Projekts verdeutlicht. Diese Entwicklung spiegelt das wachsende Interesse der Krypto-Com...

 PRESS RELEASE

EQS-News: Zimbabwe Government Delivers on Commitment: Compensation of ...

EQS-News: Zimbabwe Ministry of Finance, Economic Development and Investment Promotion / Key word(s): Miscellaneous Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences 09.04.2025 / 20:20 CET/CEST The issuer is solely responsible for the content of this announcement. In line with the GCD agreement, the FFOs receive 1 per cent of their claim in cash, with the balance being paid through US$ denominated Treasury bonds with a 2 per cent coupon and maturities of 2 to 10 years HARARE, Zimbabwe, April 9, 2025...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch